Primary cutaneous amyloidosis

Jump to: navigation, search
Primary cutaneous amyloidosis
Classification and external resources
190px
Macular amyloidosis, located on the right lumbar region of the back
ICD-9 277.3
OMIM 105250
DiseasesDB 29871

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-In-Chief: Kiran Singh, M.D. [2]

Overview

Primary cutaneous amyloidosis is a form of amyloidosis associated with oncostatin M receptor.[1][2] This type of amyloidosis has been divided into the following types:[3]:520

  • Macular amyloidosis is a cutaneous condition characterized by itchy, brown, rippled macules usually located on the interscapular region of the back.[3]:521 Combined cases of lichen and macular amyloidosis are termed biphasic amyloidosis, and provide support to the theory that these two variants of amyloidosis exist on the same disease spectrum. [4]
  • Lichen amyloidosis is a cutaneous condition characterized by the appearance of occasionally itchy lichenoid papules, typically appearing bilaterally on the shins.[3]:521
  • Nodular amyloidosis is a rare cutaneous condition characterized by nodules that involve the acral areas.[3]:521

Diagnosis

Physical Examination

Skin

Macular Amyloidosis
Lower Extremity
Trunk
Nodular Amyloidosis
Face
Lichen Amyloidosus
Extremity
Trunk

See also

References

  1. Amyloid.
  2. Arita K, South AP, Hans-Filho G, et al. (January 2008). "Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis". Am. J. Hum. Genet. 82 (1): 73–80. doi:10.1016/j.ajhg.2007.09.002. PMID 18179886.
  3. 3.0 3.1 3.2 3.3 James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 
  4. Lichen amyloidosis of the auricular concha Craig, E. (2006) Dermatology Online Journal 12 (5): 1, University of California, Davis Department of Dermatology
  5. 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 5.30 5.31 5.32 5.33 5.34 5.35 5.36 5.37 {{Cite

Amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Treatment

Medical Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary cutaneous amyloidosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary cutaneous amyloidosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary cutaneous amyloidosis

CDC on Primary cutaneous amyloidosis

Primary cutaneous amyloidosis in the news

Blogs on Primary cutaneous amyloidosis</small>

Directions to Hospitals Treating Amyloidosis

Risk calculators and risk factors for Primary cutaneous amyloidosis


References

Amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Treatment

Medical Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary cutaneous amyloidosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary cutaneous amyloidosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary cutaneous amyloidosis

CDC on Primary cutaneous amyloidosis

Primary cutaneous amyloidosis in the news

Blogs on Primary cutaneous amyloidosis</small>

Directions to Hospitals Treating Amyloidosis

Risk calculators and risk factors for Primary cutaneous amyloidosis

Cost Effectiveness of Primary cutaneous amyloidosis

| group5 = Clinical Trials Involving Primary cutaneous amyloidosis | list5 = Ongoing Trials on Primary cutaneous amyloidosis at Clinical Trials.govTrial results on Primary cutaneous amyloidosisClinical Trials on Primary cutaneous amyloidosis at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Primary cutaneous amyloidosis | list6 = US National Guidelines Clearinghouse on Primary cutaneous amyloidosisNICE Guidance on Primary cutaneous amyloidosisNHS PRODIGY GuidanceFDA on Primary cutaneous amyloidosisCDC on Primary cutaneous amyloidosis


| group7 = Textbook Information on Primary cutaneous amyloidosis | list7 = Books and Textbook Information on Primary cutaneous amyloidosis


| group8 = Pharmacology Resources on Primary cutaneous amyloidosis | list8 = AND (Dose)}} Dosing of Primary cutaneous amyloidosisAND (drug interactions)}} Drug interactions with Primary cutaneous amyloidosisAND (side effects)}} Side effects of Primary cutaneous amyloidosisAND (Allergy)}} Allergic reactions to Primary cutaneous amyloidosisAND (overdose)}} Overdose information on Primary cutaneous amyloidosisAND (carcinogenicity)}} Carcinogenicity information on Primary cutaneous amyloidosisAND (pregnancy)}} Primary cutaneous amyloidosis in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Primary cutaneous amyloidosis


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Primary cutaneous amyloidosis | list9 = AND (pharmacogenomics)}} Genetics of Primary cutaneous amyloidosisAND (pharmacogenomics)}} Pharmacogenomics of Primary cutaneous amyloidosisAND (proteomics)}} Proteomics of Primary cutaneous amyloidosis


| group10 = Newstories on Primary cutaneous amyloidosis | list10 = Primary cutaneous amyloidosis in the newsBe alerted to news on Primary cutaneous amyloidosisNews trends on Primary cutaneous amyloidosis</small>


| group11 = Commentary on Primary cutaneous amyloidosis | list11 = Blogs on Primary cutaneous amyloidosis

| group12 = Patient Resources on Primary cutaneous amyloidosis | list12 = Patient resources on Primary cutaneous amyloidosisDiscussion groups on Primary cutaneous amyloidosisPatient Handouts on Primary cutaneous amyloidosisDirections to Hospitals Treating Primary cutaneous amyloidosisRisk calculators and risk factors for Primary cutaneous amyloidosis


| group13 = Healthcare Provider Resources on Primary cutaneous amyloidosis | list13 = Symptoms of Primary cutaneous amyloidosisCauses & Risk Factors for Primary cutaneous amyloidosisDiagnostic studies for Primary cutaneous amyloidosisTreatment of Primary cutaneous amyloidosis

| group14 = Continuing Medical Education (CME) Programs on Primary cutaneous amyloidosis | list14 = CME Programs on Primary cutaneous amyloidosis

| group15 = International Resources on Primary cutaneous amyloidosis | list15 = Primary cutaneous amyloidosis en EspanolPrimary cutaneous amyloidosis en Francais

| group16 = Business Resources on Primary cutaneous amyloidosis | list16 = Primary cutaneous amyloidosis in the MarketplacePatents on Primary cutaneous amyloidosis

| group17 = Informatics Resources on Primary cutaneous amyloidosis | list17 = List of terms related to Primary cutaneous amyloidosis


}}


Linked-in.jpg